AI in biopharma marketing

Balancing opportunities & regulation

On demand

Watch us for a 50-minute webinar, in which our panel of digital experience, biopharma, AI, and legal experts explore ways biopharmas can start capitalizing on GenAI for marketing now while successfully navigating regulatory risks.

BalancingOpportunitiesandRegulations_Social - Thumbnail copy

About the webinar

AI holds tremendous potential for revolutionizing biopharma marketing. Teams can tap into a broad range of use cases—from tailoring content for multiple target audiences, channels, and formats to analyzing large sets of customer sentiment data and rapidly responding to HCP and patient queries. 

But while AI can help enhance digital experiences and boost engagement, biopharmas implementing AI in marketing must navigate serious regulatory risks and industry-specific challenges.

Our panel of experts will showcase real-world applications of GenAI in biopharma marketing and discuss strategies for mitigating risks.

Watch our webinar to discover:

  • AI use cases that can improve HCP and patient engagement by streamlining the creation and distribution of personalized, compliant content
  • Tactics for implementing AI in a safe, secure, and trusted way, with necessary AI governance
  • Approaches for successfully balancing opportunities and risks—and even using AI to expedite the MLR process

Treffen Sie unsere Experten

GenAI-Experten im Biopharma-Marketing

Christina Schiffler

Executive Director & Design Principal, IBM iX

Christina Schiffler heads an industry cluster and the Digital Marketing & Communication Practice at IBM iX Studio Berlin with a focus on content and media production. She is a creative strategist, communications expert and trained journalist with over 25 years of professional experience. Lately, she's been daydreaming about how much time she can save with AI tools - just to remind herself of the value of creativity. Together with her team, she has developed, among other things, a content editor that will save up to 75% of time.

Jan Hulshoff Pol

Head of Digital Healthcare Marketing, Berlin-Chemie

Jan Hulshoff Pol has been involved in digital health since developing health coaching at the eHealth start-up Hausmed in 2013. At Berlin-Chemie, Jan is responsible for the digital therapy platform TheraKey.de, among other things, and is currently developing it further for the indications COPD and asthma.

Boris Arendt

Direktor, Simpliant legal

Boris Arendt has more than 15 years of experience as a lawyer and consultant in the fields of data protection and IT security and headed the data protection team of a global manufacturer of medical devices for four years. At Simpliant, Boris primarily advises companies on data protection law and information security issues. He also supports companies in the implementation of legal and regulatory requirements in connection with the development and use of artificial intelligence.

Jan Schulte

Head of Group Consulting, Magnolia

Working at the intersection of business and technology, Jan helps Magnolia clients succeed with their content management and digital experience initiatives, framing solutions to their custom challenges and opportunities.